US Patent

US9567363 — Certain compounds, compositions and methods

Composition of Matter · Assigned to Otsuka Pharmaceutical Co Ltd · Expires 2028-10-16 · 2y remaining

Vulnerability score 17/100 Ironclad — strong claim type, well-established, deep family

What this patent protects

This patent protects certain tetrahydrouridine derivative compounds and methods of making and using them.

USPTO Abstract

The present invention provides certain tetrahydrouridine derivative compounds, pharmaceutical compositions and kits comprising such compounds, and methods of making and using such compounds.

Drugs covered by this patent

Patent Metadata

Patent number
US9567363
Jurisdiction
US
Classification
Composition of Matter
Expires
2028-10-16
Drug substance claim
Yes
Drug product claim
No
Assignee
Otsuka Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.